Heparin and N-acetylcysteine for the treatment of lung injury
Grant
US12576103B2
Kind: B2
Mar 17, 2026
Assignee
Atossa Therapeutics, Inc.
Inventors
Steven C. Quay
Abstract
Disclosed herein are compositions and methods for treatment or prevention of a respiratory viral infection. A composition of the present disclosure comprises one or more of heparin, or N-acetylcysteine. A composition for treatment or prevention of a respiratory viral infection may be administered by inhalation in intervals. Administration of a composition may treat or prevent a viral infection.
CPC Classifications
A61K 31/727
A61K 9/0078
A61K 31/198
A61K 45/06
A61K 47/183
Filing Date
2021-03-19
Application No.
17802711
Claims
16